Adverum Stock Analysis

Adverum Stock Analysis Notes

About 58.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.3. Some equities with similar Price to Book (P/B) outperform the market in the long run. Adverum Biotechnologies recorded a loss per share of 1.69. The entity had not issued any dividends in recent years. Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California. Adverum Biotechnlgs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 188 people. For more info on Adverum Biotechnologies please contact Laurent Fischer at 650 656 9323 or go to https://www.adverum.com.

Adverum Biotechnologies Investment Alerts

Adverum Biotechnologies Upcoming and Recent Events

Adverum Biotechnologies SEC Filings

Adverum Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 78.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adverum Biotechnologies's market, we take the total number of its shares issued and multiply it by Adverum Biotechnologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Adverum Profitablity

Management Efficiency

The entity has return on total asset (ROA) of (0.2293) % which means that it has lost $0.2293 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.5636) %, meaning that it created substantial loss on money invested by shareholders. Adverum Biotechnologies management efficiency ratios could be used to measure how well adverum biotechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of 30th of March 2023, Return on Investment is likely to drop to -48.32. In addition to that, Return on Average Assets is likely to drop to -0.38. Adverum Biotechnologies Tangible Asset Value is very stable at the moment as compared to the past year. Adverum Biotechnologies reported last year Tangible Asset Value of 505.69 Million

Technical Drivers

Adverum Biotechnologies Price Movement Analysis

Adverum Biotechnologies Insider Trading Activities

Adverum Biotechnologies Predictive Daily Indicators

Adverum Biotechnologies Forecast Models

Adverum Biotechnologies time-series forecasting models is one of many Adverum Biotechnologies' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Adverum Biotechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Adverum Biotechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Adverum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Adverum Biotechnologies. By using and applying Adverum Stock analysis, traders can create a robust methodology for identifying Adverum entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Adverum analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Adverum analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Adverum Biotechnologies stock analysis indicators help investors evaluate how Adverum Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Adverum Biotechnologies shares will generate the highest return on investment. By understating and applying Adverum Biotechnologies stock analysis, traders can identify Adverum Biotechnologies position entry and exit signals to maximize returns.

Check out Trending Equities. To learn how to invest in Adverum Stock please use our How to Invest in Adverum Biotechnologies guide. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

When running Adverum Biotechnologies price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.

Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Adverum Biotechnologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.